RSS
22 Feb 2023

New Cardinal Health report examines shifts in biosimilars industry

Author: admintech | Filed under: Press Release

Study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments DUBLIN, Ohio, Feb. 22, 2023 /PRNewswire/ — Today, Cardinal Health (NYSE: CAH) released its 2023 Biosimilars…

This entry was posted on Wednesday, February 22nd, 2023 at 7:13 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»